Autonomic Nervous System Drugs Practice Questions

Q: Curare poisoning is characterised by:

Hypotension. **Explanation:** Curare (specifically **d-Tubocurarine**) is a prototype non-depolarizing neuromuscular blocking agent. The primary reason for **Hypotension** in curare poisoning is twofold: 1. **Histamine Release:** d-Tubocurarine is a potent stimulator of mast cells, leading to significant histamine release. Histamine causes peripheral vasodilation and increased capillary permeability, resulting in a drop in blood pressure. 2. **Ganglionic Blockade:** In high doses, curare blocks nicotinic receptors ($N_n$) at the autonomic ganglia, reducing sympathetic tone to the blood vessels and further contributing to hypotension. **Analysis of Incorrect Options:** * **A. Hypertension:** This is incorrect because curare lacks sympathomimetic activity; its ganglionic blocking and histamine-releasing properties lead to a decrease, not an increase, in blood pressure. * **C. Does not release histamine:** This is incorrect. d-Tubocurarine is notorious for histamine release, which can also trigger bronchospasm and excessive secretions, making it risky for asthmatic patients. * **D. Oral route of administration:** This is incorrect. Curare is highly ionized (quaternary ammonium compound) and is **not absorbed from the gastrointestinal tract**. Historically, indigenous hunters used curare-tipped arrows to kill prey; the meat remained safe to eat because the toxin is not absorbed orally. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** Neostigmine (AChE inhibitor) is used to reverse the blockade by increasing acetylcholine levels at the NMJ. * **Order of Paralysis:** Small, rapid muscles (eyes, fingers) are affected first; the **diaphragm** is the last to be paralyzed and the first to recover. * **Modern Alternative:** **Vecuronium** and **Rocuronium** are preferred in clinical practice as they do not cause histamine release or ganglionic blockade, ensuring hemodynamic stability.

Q: Which is the most dangerous effect of belladonna in very young children?

Hyperthermia. **Explanation:** The correct answer is **Hyperthermia**. Belladonna alkaloids (like Atropine) are competitive antagonists at muscarinic receptors. In children, the most critical adverse effect is "Atropine fever." **1. Why Hyperthermia is the correct answer:** Atropine suppresses the activity of eccrine sweat glands by blocking **M3 receptors**. Since sweating is the body's primary mechanism for heat dissipation, its inhibition leads to a rapid rise in body temperature. Children are particularly vulnerable because their thermoregulatory centers are immature and they have a higher surface-area-to-body-mass ratio. In severe cases, this can lead to fatal hyperpyrexia. **2. Why the other options are incorrect:** * **Dehydration:** While belladonna causes "dryness" (dry mouth, dry skin), it does not cause systemic fluid loss or dehydration. The danger is the inability to cool down, not a lack of total body water. * **Hallucinations:** Central Nervous System (CNS) effects like delirium and hallucinations occur (the "Mad as a hatter" sign), but these are generally manageable and less life-threatening than extreme hyperpyrexia. * **Hypertension:** Atropine typically causes tachycardia, but it does not have a significant or dangerous effect on blood pressure in children compared to the risk of hyperthermia. **Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Poisoning:** "Hot as a hare (Hyperthermia), Red as a beet (Flushing), Dry as a bone (Anhidrosis), Blind as a bat (Mydriasis), Mad as a hatter (Delirium)." * **Antidote:** The drug of choice for belladonna poisoning is **Physostigmine** (a tertiary amine carbamate that crosses the Blood-Brain Barrier). * **Contraindication:** Atropine is contraindicated in patients with narrow-angle glaucoma and prostatic hypertrophy.

Q: Which of the following is NOT a use of anticholinergics?

Tachycardia. **Explanation:** Anticholinergics (Muscarinic antagonists) act by blocking the action of acetylcholine at M-receptors. One of the hallmark effects of these drugs on the heart is the blockade of M2 receptors in the SA node, which leads to an **increase in heart rate (Tachycardia)**. Therefore, anticholinergics are used to treat *bradycardia* (e.g., Atropine in ACLS), but they are contraindicated in patients with pre-existing tachycardia as they would exacerbate the condition. **Why the other options are uses of Anticholinergics:** * **Peptic Ulcer Disease (PUD):** Drugs like **Pirenzepine** (selective M1 blocker) were historically used to reduce gastric acid secretion, though they are now largely replaced by PPIs. * **Motion Sickness:** **Hyoscine (Scopolamine)** is the drug of choice. It acts on the vestibular apparatus and the vomiting center in the brain to prevent nausea and vomiting associated with motion. * **Spasmodic Pain:** Anticholinergics like **Dicyclomine** and **Hyoscine butylbromide** act as antispasmodics by relaxing the smooth muscles of the GI and biliary tracts, providing relief from colic. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for Mushroom poisoning (Inocybe type):** Atropine. * **Ipratropium/Tiotropium:** M3 blockers used via inhalation for COPD and Asthma (Bronchodilators). * **Oxybutynin/Darifenacin:** Used for overactive bladder (Urinary incontinence). * **Contraindications:** Anticholinergics should be avoided in **Glaucoma** (causes mydriasis/increased IOP) and **Benign Prostatic Hyperplasia (BPH)** (causes urinary retention).

Q: What is the primary reason dopamine is preferred in the treatment of shock?

Renal vasodilatory effect. **Explanation:** The primary reason dopamine is preferred in the management of shock (particularly cardiogenic or septic shock) is its unique, dose-dependent effect on renal hemodynamics. **1. Why Option A is Correct:** At low doses (**0.5–2 µg/kg/min**), dopamine acts primarily on **D1 receptors** located in the renal, mesenteric, and coronary vascular beds. Activation of these receptors causes vasodilation, increasing renal blood flow and glomerular filtration rate (GFR). This helps maintain urine output and prevents acute tubular necrosis (renal failure), a common complication of shock. **2. Why Other Options are Incorrect:** * **Option B:** While dopamine does increase cardiac output via **β1 receptors** (at medium doses: 2–10 µg/kg/min), other inotropes like Dobutamine are more potent and selective for this purpose. The "preference" for dopamine specifically highlights its renal-sparing property. * **Option C:** Peripheral vasoconstriction occurs at high doses (>10 µg/kg/min) via **α1 receptors**. This is generally undesirable in many shock states as it increases afterload and can further decrease organ perfusion. * **Option D:** Dopamine has a very short half-life (approx. 2 minutes) and must be administered via continuous IV infusion. It does not have a prolonged action. **High-Yield Clinical Pearls for NEET-PG:** * **Dose-Dependent Action:** Remember the mnemonic **"DBA"** (Dopaminergic → Beta → Alpha) as the dose increases. * **Fenoldopam:** A selective D1 agonist used for hypertensive emergencies; it also maintains renal perfusion. * **Drug of Choice:** While dopamine was traditionally favored, current guidelines (like Surviving Sepsis) often prefer **Norepinephrine** as the first-line vasopressor for septic shock, but dopamine remains a high-yield answer for its renal vasodilatory profile in exams.

Q: Which enzyme acts on suxamethonium?

Suxamethonium. **Explanation:** The correct answer is **Suxamethonium** (also known as Succinylcholine). **Mechanism and Metabolism:** Suxamethonium is a depolarizing neuromuscular blocking agent. It is unique because it is not metabolized by acetylcholinesterase at the neuromuscular junction. Instead, it is rapidly hydrolyzed by **Pseudocholinesterase** (also known as Butyrylcholinesterase or Plasma cholinesterase), an enzyme synthesized in the liver and found in the plasma. This rapid metabolism accounts for its short duration of action (5–10 minutes), making it the drug of choice for rapid sequence induction. **Analysis of Options:** * **Decamethonium (Option A):** This is a depolarizing muscle relaxant similar to suxamethonium, but it is not metabolized by cholinesterases; it is excreted unchanged by the kidneys. * **Tubocurarine (Option B):** A prototype non-depolarizing blocker. It is primarily eliminated by the kidneys and liver and is not a substrate for pseudocholinesterase. * **Gallamine (Option C):** A non-depolarizing blocker that is excreted entirely unchanged by the kidneys. **High-Yield Clinical Pearls for NEET-PG:** 1. **Suxamethonium Apnea:** Occurs in patients with an atypical or deficient pseudocholinesterase enzyme (prolonged paralysis). Diagnosis is made using the **Dibucaine Number** (Normal = 80; Heterozygous = 40-60; Homozygous atypical = 20). 2. **Phase II Block:** Occurs with high doses or continuous infusion of suxamethonium, where the block changes from depolarizing to non-depolarizing characteristics. 3. **Contraindications:** Avoid in patients with burns, massive trauma, or nerve injuries due to the risk of life-threatening **hyperkalemia**. 4. **Side Effects:** Muscle fasciculations, myalgia, increased intraocular/intragastric pressure, and it is a known trigger for **Malignant Hyperthermia**.

Q: Propranolol is useful in all the following conditions EXCEPT:

Parkinsonian tremor. **Explanation:** Propranolol is a non-selective beta-blocker ($B_1$ and $B_2$) with high lipid solubility. The correct answer is **Parkinsonian tremor** because its pathophysiology and treatment differ significantly from other types of tremors. **1. Why Parkinsonian Tremor is the Correct Answer:** Parkinsonian tremor is a **resting tremor** caused by a dopamine deficiency in the nigrostriatal pathway. The mainstay of treatment involves increasing dopamine (Levodopa) or using central anticholinergics (Benztropine). Propranolol is ineffective here. In contrast, Propranolol is the **drug of choice for Essential Tremor** (action tremor), which is mediated by peripheral $B_2$ receptors. **2. Analysis of Incorrect Options:** * **Atrial Flutter:** Propranolol is a Class II antiarrhythmic. It decreases the heart rate by slowing AV node conduction, making it useful for rate control in supraventricular tachycardias. * **Thyrotoxicosis:** Propranolol is used to manage symptomatic sympathetic overactivity (palpitations, tremors). Crucially, it also **inhibits the peripheral conversion of $T_4$ to the more active $T_3$**, making it the preferred beta-blocker in thyroid storm. * **Hypertrophic Cardiomyopathy (HCM/HOCM):** It is a first-line agent. By decreasing the heart rate and contractility (negative inotropy), it increases diastolic filling time and reduces the left ventricular outflow tract (LVOT) gradient. **Clinical Pearls for NEET-PG:** * **Membrane Stabilizing Activity (MSA):** Propranolol possesses local anesthetic-like effects (Quinidine-like), making it dangerous in overdose. * **Lipid Solubility:** High lipid solubility allows it to cross the BBB, causing side effects like vivid dreams or depression, but also making it effective for **Migraine Prophylaxis**. * **Contraindications:** Always avoid in Bronchial Asthma (due to $B_2$ blockade) and Prinzmetal Angina.

Q: Aggravation of myasthenia gravis is a feature of all the following drugs except?

Edrophonium. **Explanation:** The correct answer is **Edrophonium**. This question tests your understanding of drugs that interfere with neuromuscular transmission versus those that enhance it. **1. Why Edrophonium is correct:** Edrophonium is a short-acting **reversible acetylcholinesterase inhibitor**. By inhibiting the enzyme that breaks down acetylcholine (ACh) in the synaptic cleft, it increases the concentration of ACh available to bind to nicotinic receptors at the neuromuscular junction (NMJ). This **improves** muscle strength in Myasthenia Gravis (MG) patients. Historically, it was used in the **Tensilon Test** to diagnose MG. **2. Why the other options are wrong:** * **Gentamicin & Neomycin (Aminoglycosides):** These antibiotics are notorious for aggravating MG. They inhibit the pre-synaptic release of acetylcholine and reduce post-synaptic sensitivity to ACh. They are generally contraindicated or used with extreme caution in MG patients. * **Succinylcholine:** This is a depolarizing neuromuscular blocker. MG patients have a reduced number of functional nicotinic receptors; they are often resistant to succinylcholine initially, but it can lead to a prolonged Phase II block, causing unpredictable and potentially severe respiratory depression/aggravation of weakness. **Clinical Pearls for NEET-PG:** * **Drugs to avoid in MG:** Aminoglycosides, Quinolones, Beta-blockers, Lithium, Magnesium salts, and Procainamide. * **Tensilon Test:** Edrophonium is used to differentiate between a **Myasthenic Crisis** (improvement seen) and a **Cholinergic Crisis** (worsening seen due to depolarization block). * **Treatment of choice for MG:** Pyridostigmine (longer-acting cholinesterase inhibitor) is the first-line oral treatment.

Q: Which precursor of adrenaline is responsible for renal vasodilation?

Dopamine. **Explanation:** The correct answer is **Dopamine**. **Why Dopamine is correct:** Dopamine is the immediate biochemical precursor of Noradrenaline and Adrenaline in the catecholamine synthesis pathway (Tyrosine → L-Dopa → Dopamine → Noradrenaline → Adrenaline). At low doses (0.5–2 µg/kg/min), dopamine acts on **D1 receptors** located in the renal, mesenteric, and coronary vascular beds. Activation of these receptors leads to **vasodilation**, increasing renal blood flow and the glomerular filtration rate (GFR). **Why the other options are incorrect:** * **Adrenaline:** While it is the final product of the pathway, it acts primarily on $\alpha$ and $\beta$ receptors. At therapeutic doses, it typically causes vasoconstriction in the skin and viscera ($\alpha_1$) and vasodilation in skeletal muscle ($\beta_2$), but it does not have a specific vasodilatory effect on renal vessels like dopamine. * **Noradrenaline:** This is a potent $\alpha_1$ and $\alpha_2$ agonist with some $\beta_1$ activity. It causes intense systemic vasoconstriction, which can actually reduce renal blood flow. * **Acetylcholine:** This is the primary neurotransmitter of the parasympathetic nervous system. While it can cause vasodilation via nitric oxide release, it is not a precursor to adrenaline. **High-Yield Clinical Pearls for NEET-PG:** * **Dose-Dependent Effects of Dopamine:** * **Low dose (D1):** Renal vasodilation ("Renal dose"). * **Medium dose ($\beta_1$):** Positive inotropic effect on the heart. * **High dose ($\alpha_1$):** Systemic vasoconstriction. * **Fenoldopam:** A selective D1 agonist used in hypertensive emergencies to maintain renal perfusion. * **Rate-limiting step:** Tyrosine hydroxylase is the rate-limiting enzyme in catecholamine synthesis.

Q: A patient complains of muscle weakness. This weakness is reversed on administration of neostigmine. What is the mechanism of action of neostigmine in this scenario?

It interferes with the action of acetylcholine esterase.. ### Explanation **1. Why Option D is Correct:** Neostigmine is a **reversible anticholinesterase** agent. In conditions like Myasthenia Gravis, muscle weakness occurs due to a reduction in functional nicotinic acetylcholine receptors (Nm) at the neuromuscular junction. Neostigmine works by binding to and inhibiting the enzyme **Acetylcholinesterase (AChE)**. This enzyme is responsible for the degradation of Acetylcholine (ACh) into choline and acetate. By inhibiting AChE, neostigmine prevents the breakdown of ACh, leading to an increased concentration and prolonged duration of action of ACh at the synaptic cleft [1]. This allows more ACh to interact with the remaining receptors, thereby improving muscle strength. **2. Why Other Options are Incorrect:** * **Option A:** Blocking the action of ACh (like Atropine or Curare) would worsen muscle weakness, not reverse it. * **Option B:** Monoamine oxidase (MAO) inhibitors are used in psychiatry (depression) and Parkinson’s disease; they affect catecholamines (Dopamine, NE), not the neuromuscular junction. * **Option C:** Carbonic anhydrase inhibitors (like Acetazolamide) are used for glaucoma or altitude sickness and have no direct effect on cholinergic transmission. **3. Clinical Pearls for NEET-PG:** * **Structure:** Neostigmine is a **quaternary ammonium** compound; it is polar and **does not cross the blood-brain barrier (BBB)**. * **Clinical Uses:** Treatment of Myasthenia Gravis, reversal of non-depolarizing muscle relaxants (e.g., Vecuronium), and postoperative paralytic ileus/urinary retention. * **Side Effects:** Excessive muscarinic stimulation (miosis, bradycardia, salivation). These are often managed by co-administering **Atropine or Glycopyrrolate**. * **Diagnostic Test:** While Neostigmine is used for treatment, **Edrophonium** (Tensilon test) is the classic short-acting agent used for diagnosis.

Question 1

Curare poisoning is characterised by:

Accepted Answer

Hypotension

Answer

Hypertension

Answer

Does not release histamine

Answer

Oral route of administration is the best route

Question 2

Which is the most dangerous effect of belladonna in very young children?

Accepted Answer

Hyperthermia

Answer

Dehydration

Answer

Hallucinations

Answer

Hypertension

Question 3

Which of the following is NOT a use of anticholinergics?

Accepted Answer

Tachycardia

Answer

Peptic ulcer disease

Answer

Motion sickness

Answer

Spasmodic pain

Question 4

What is the primary reason dopamine is preferred in the treatment of shock?

Accepted Answer

Renal vasodilatory effect

Answer

Increased cardiac output

Answer

Peripheral vasoconstriction

Answer

Prolonged action

Question 5

Which enzyme acts on suxamethonium?

Accepted Answer

Suxamethonium

Answer

Decamethonium

Answer

Tubocurarine

Answer

Gallamine

Question 6

Propranolol is useful in all the following conditions EXCEPT:

Accepted Answer

Parkinsonian tremor

Answer

Atrial flutter

Answer

Thyrotoxicosis

Answer

Hypertrophic cardiomyopathy

Question 7

Aggravation of myasthenia gravis is a feature of all the following drugs except?

Accepted Answer

Edrophonium

Answer

Gentamicin

Answer

Neomycin

Answer

Succinylcholine

Question 8

A drug is a tertiary amine while another drug is a quaternary ammonium compound. Which of the following statements is true regarding these drugs?

Accepted Answer

The tertiary amine will be more suitable to be used as a miotic.

Answer

The tertiary amine is likely to be more potent than the quaternary ammonium compound.

Answer

The quaternary ammonium compound will produce CNS effects.

Answer

The quaternary ammonium compound will be completely metabolized in the body.

Question 9

Which precursor of adrenaline is responsible for renal vasodilation?

Accepted Answer

Dopamine

Answer

Adrenaline

Answer

Noradrenaline

Answer

Acetylcholine

Question 10

A patient complains of muscle weakness. This weakness is reversed on administration of neostigmine. What is the mechanism of action of neostigmine in this scenario?

Accepted Answer

It interferes with the action of acetylcholine esterase.

Answer

It blocks the action of acetylcholine.

Answer

It interferes with the action of monoamine oxidase.

Answer

It interferes with the action of carbonic anhydrase.

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?